NeueHealth(NEUE)

Search documents
NeueHealth(NEUE) - 2021 Q3 - Earnings Call Presentation
2021-11-17 11:33
| --- | --- | |-------------------------------------------------------------------|-------| | | | | | | | | | | Bright Health Group Third Quarter 2021 – Earnings Presentation | | | November 11, 2021 | | Disclaimer 2 Statements made in this presentation that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements, and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results ...
NeueHealth(NEUE) - 2021 Q3 - Quarterly Report
2021-11-15 13:03
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 BRIGHT HEALTH GROUP, INC. (Exact Name of Registrant as Specified in its Charter) | Delaware | 47-4991 ...
NeueHealth(NEUE) - 2021 Q3 - Earnings Call Transcript
2021-11-11 19:01
Bright Health Group, Inc. (BHG) Q3 2021 Earnings Conference Call November 11, 2021 8:00 AM ET Company Participants Mike Mikan - President and Chief Executive Officer Cathy Smith - Chief Financial Officer and Chief Administrative Officer Simeon Schindelman - Chief Executive Officer, Bright HealthCare Sam Srivastava - Chief Executive Officer, NeueHealth Conference Call Participants Kevin Fischbeck - Bank of America Lisa Gill - JPMorgan Joshua Raskin - Nephron Research Ricky Goldwasser - Morgan Stanley Jeff Ga ...
NeueHealth(NEUE) - 2021 Q2 - Quarterly Report
2021-08-11 20:32
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 BRIGHT HEALTH GROUP, INC. (Exact Name of Registrant as Specified in its Charter) | Delaware | 47-4991296 | ...
NeueHealth(NEUE) - 2021 Q2 - Earnings Call Transcript
2021-08-07 16:15
Bright Health Group, Inc. (BHG) Q2 2021 Results Earnings Conference Call August 3, 2021 8:00 AM ET Company Participants Mike Mikan - Vice Chairman, President and CEO Cathy Smith - Chief Financial and Administrative Officer Sam Srivastava - CEO, NeueHealth Simeon Schindelman - CEO, Bright HealthCare Conference Call Participants Terence Flynn - Goldman Sachs Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Justin Lake - Wolfe Research Jeff Garro - Piper Sandler Lisa Gill - JPMorgan Craig Hette ...
NeueHealth(NEUE) - 2021 Q2 - Earnings Call Presentation
2021-08-04 15:22
| --- | --- | |-------------------------------------------------------------------|-------| | | | | | | | | | | Bright Health Group Second Quarter 2021 – Earnings Presentation | | | August 3, 2021 | | Disclaimer 2 Statements made in this presentation that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements, and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of ...